Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will ...

(MENAFN- EIN Presswire) EINPresswire/ -- The DNA Diagnostics Market stood at USD 29.2 billion in 2025 and is forecast to expand to USD 61.9 billion by 2035, reflecting a steady 7.8% CAGR over the ...

The latest update to Insight Molecular Diagnostics has seen the analyst price target move to US$12, while the fair value estimate remains at US$8.33 per share. Analysts linking this shift to the ...

IDT announces the launch of Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx in vitro diagnostic (IVD) offerings. "At IDT, we believe that precision diagnostics should be as reliable as they are ...

Milestone marks first of multiple planned diagnostic product launches on NGS roadmap Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

The MarketWatch News Department was not involved in the creation of this content. -- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer ...

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage whole-genome cell-free DNA (cfDNA) assays for cancer detection and monitoring, today announced it will present five ...

MyGevity today announced the nationwide launch of its precision health platform, connecting at-home genetic testing directly to real-time lab diagnostics -- turning static DNA data into a living, ...

BOULDER, Colo., March 23, 2026--(BUSINESS WIRE)--Global genomics leader Integrated DNA Technologies (IDT) today announced the launch of Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx in vitro ...